TX HCR 103
died on adjournmentExpressing support for the Texas Health and Human Services Commission's application to the Cell and Gene Therapy Access Model through the Centers for Medicare and Medicaid Services and its Center for Medicare and Medicaid Innovation.
Texas · 89th Legislature (2025 Regular Session) · lower
Quick answers
Did TX HCR 103 pass?
No. TX HCR 103 died when the 89th Legislature (2025 Regular Session) adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2025-03-17): Referred to s/c on Dis Prev & Women's & Children's Health by Speaker
What is TX HCR 103 about?
TX HCR 103 is a concurrent resolution in the 89th Legislature (2025 Regular Session) titled “Expressing support for the Texas Health and Human Services Commission's application to the Cell and Gene Therapy Access Model through the Centers for Medicare and Medicaid Services and its Center for Medicare and Medicaid Innovation.”.
Who sponsors TX HCR 103?
Simmons is the primary sponsor of TX HCR 103.
- Introduced
- —
- Latest action
- 2025-03-17 — Referred to s/c on Dis Prev & Women's & Children's Health by Speaker
- Bill type
- concurrent resolution
- Last updated
- —
Subjects
Sponsors
- Simmonsprimary
Committees
Not provided by source.
Action timeline
2025-03-07
Filed
filing
2025-03-17
Referred to s/c on Dis Prev & Women's & Children's Health by Speaker
referral-committee
Versions
- IntroducedCompare
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:33:51.767464Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=TX&identifier=HCR 103. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.